首页> 外文OA文献 >PCN72 HEALTH-RELATED QUALITY OF LIFE (HRQOL)AND KIDNEY CANCER-RELATED SYMPTOMS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)TREATED WITH SUNITINIB VERSUS INTERFERON (IFN)-ALFA IN A RANDOMISED, MULTINATIONAL PHASE III TRIAL: RESULTS FOR EUROPEAN AND US SUBSAMPLE ANALYSES

【2h】

PCN72 HEALTH-RELATED QUALITY OF LIFE (HRQOL)AND KIDNEY CANCER-RELATED SYMPTOMS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)TREATED WITH SUNITINIB VERSUS INTERFERON (IFN)-ALFA IN A RANDOMISED, MULTINATIONAL PHASE III TRIAL: RESULTS FOR EUROPEAN AND US SUBSAMPLE ANALYSES

机译：经随机，多次欧洲和第三阶段治疗的经舒尼替尼抗干扰素（IFN）-α治疗的转移性肾细胞癌（MRCC）患者的PCN72生命质量（HRQOL）和肾癌相关症状子样本分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Celia D; Li JZ; Bushmakin AG; Cappelleri JC; Kim ST; Chen I; Charbonneau C; Motzer RJ;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. 1108 POSTER Health-related quality of life (HRQOL) and kidney cancer-related symptoms in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib versus interferon (IFN)-alfa: results for European and US subsample analyses in a randomized, multinational phase III trial [J] . D.Cella, J.Z.Li, A.G.Bushmakin, European Journal of Cancer Supplements . 2007,第4期

机译：1108海报舒尼替尼与干扰素（α）治疗的转移性肾细胞癌（mRCC）患者的健康相关生活质量（HRQOL）和肾癌相关症状：欧洲和美国随机，多国三期试验
2. Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trial. [J] . Cella D, Li JZ, Cappelleri JC, Journal of Clinical Oncology . 2008,第22期

机译：舒尼替尼或干扰素α治疗的转移性肾细胞癌患者的生活质量：III期随机试验的结果。
3. Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-|[alpha]| in a phase III trial: final results and geographical analysis [J] . D Cella, M D Michaelson, A G Bushmakin, British Journal of Cancer . 2010,第4期

机译：舒尼替尼与干扰素-|α|治疗的转移性肾细胞癌患者的健康相关生活质量在III期试验中：最终结果和地理分析
4. Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-α in a phase III trial: final results and geographical analysis [O] . D Cella, M D Michaelson, A G Bushmakin, 2010

机译：舒尼替尼与干扰素-α治疗的转移性肾细胞癌患者的健康相关生活质量的III期试验：最终结果和地理分析
5. PCN75 AN UPDATED GEOGRAPHIC SUBPOPULATION ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) ENROLLED IN A PHASE III TRIAL OF SUNITINIB VERSUS INTERFERON-ALFA [O] . Cella D, Bushmakin AG, Cappelleri JC, 2008

机译：PCN75进行了SUNITINIB与干扰素-α的III期临床试验相关的转移性肾细胞癌（MRCC）患者生命相关质量（HRQOL）的最新地理亚群分析

PCN72 HEALTH-RELATED QUALITY OF LIFE (HRQOL)AND KIDNEY CANCER-RELATED SYMPTOMS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)TREATED WITH SUNITINIB VERSUS INTERFERON (IFN)-ALFA IN A RANDOMISED, MULTINATIONAL PHASE III TRIAL: RESULTS FOR EUROPEAN AND US SUBSAMPLE ANALYSES

著录项

相似文献

相关主题

期刊订阅